Do More With Reuters
Partner Services

UPDATE 1-King Pharma profit falls as Altace sales dive

Thu May 8, 2008 5:06pm IST
 
Email | Print | | Single Page
[-] Text [+]

(Rewrites first paragraph; adds details)

NEW YORK, May 8 (Reuters) - King Pharmaceuticals Inc (KG.N: Quote, Profile, Research) posted a 24 percent drop in first-quarter profit on Thursday as sales of its Altace blood-pressure drug plunged due to competition from generics.

Net income fell to $87.6 million, or 36 cents per share, from $115.9 million, or 48 cents per share, a year earlier.

Excluding one-time items, earnings were 37 cents per share, 2 cents ahead of analysts' average forecast, according to Reuters Estimates.

Revenue fell 16 percent to $432 million.

Sales of Altace, King's biggest-selling medicine until recently, dropped nearly 50 percent to $80 million. Altace began seeing U.S. competition from generic copies in December.

Sales of King's Skelaxin muscle relaxant nudged up 4 percent to $116 million. Sales of its Thrombin JMI product for controlling bleeding rose nearly 5 percent to $67 million.

Last October King said it would cut its work force by 20 percent, or 520 jobs, after its Altace patent was declared invalid. (Reporting by Lewis Krauskopf; Editing by Steve Orlofsky and John Wallace)

Russian Finance Minister Alexey Kudrin poses with his G20 colleagues and central bank leaders during the family photo at the G20 Finance Ministers meeting at a hotel in St. Andrews, Scotland. REUTERS/POOL New
Pledge to support economies

G20 financial leaders pledged to prepare strategies to end emergency support for their economies, but to keep the aid flowing until recovery was assured.  Full Article | Related Story 

Market Update

  • IndiaIndia
  • USUS
  • UKUK
  • Asia
  • Most Actives

SHOWCASE

Sanjay Sinha
Balancing Act

In India, it is a tough choice between growth, managing inflation and financial stability.  Full Article 

 
Nipun Mehta
Road to Recovery

There needs to be an acceptable balance created between education and healthcare and infrastructure spend, says Nipun Mehta of SG Private Banking.   Full Article 

 
Robot Asimo

Snapshots of Honda Motor's humanoid robot Asimo  Slideshow 

 
Marketing Strategy
Marketing Strategy

Companies are now using direct marketing methods to sell their products.  Full Article 

 
Exit Plans
Exit Plans

Factbox - Stimulus exit plans for Asia-Pacific's big 5 economies  Full Article